Thorne, MD, PhD, discusses evidence from the ADJUST trial, including relapse risk, retreatment success, and how clinicians ...

Founded in 2016, VivaVision Biotech is a late clinical-stage biopharmaceutical company dedicated to advancing first/best-in-class therapies for ocular diseases. The company’s leading pipeline assets ...

WENZHOU, China, Jan. 6, 2026 /PRNewswire/ -- Recently, VivaVision Biotech (VivaVision), a late clinical-stage, privately-held biotech company focused on developing innovative ophthalmic drugs, ...

A North Yorkshire pony breeder has credited Rainbow Equine Hospital in Malton for saving the life of Parlington Flair, a ...

A North Yorkshire pony breeder has credited Rainbow Equine Hospital in Malton for saving the life of Parlington Flair, a seriously ...

A pony breeder has praised a Ryedale equine hospital for saving the life of their seriously ill Miniature Shetland Pony and ...

Patients who experience adverse ocular effects with bisphosphonates have a notably higher risk for osteonecrosis than those who do not experience such events, a large cohort study shows.

Investing.com – Leerink Partners hat das "Outperform"-Rating und das Kursziel von 32,00 US-Dollar für die Aktie von Roivant Sciences (NASDAQ:ROIV) bestätigt und begründet dies mit der Erwartung positi ...

Sudden blindness striking days after a routine tooth pull feels like a nightmare no one sees coming. This real case, handled ...

This week’s Community Spotlight honoree is Ashley Shannon Price, 51, childcare director at the Reading YMCA, who helps ...

Running separate protocols for multiple investigational products and disease subpopulations slows development and duplicates infrastructure. There is growing interest in accelerating drug development ...

Novoron Bioscience, a San Diego-based biotechnology company developing therapies for neurodegenerative diseases and neurological injury, has received a $2.5 million Small Business Innovation Research ...